Tc-99m and Re-186 complexes of tetraphosphonate ligands and their biodistribution pattern in animal models

被引:25
作者
Banerjee, S
Samuel, G
Kothari, K
Unni, PR
Sarma, HD
Pillai, MRA [1 ]
机构
[1] Bhabha Atom Res Ctr, Radiopharmaceut Div, Mumbai 400085, India
[2] Bhabha Atom Res Ctr, Div Radiat Biol, Mumbai 400085, India
关键词
Tetraphosphonates; Tc-99m complexes; Re-186; complexes; Tc-99m-MDP; Re-186-HEDP; skeletal imaging;
D O I
10.1016/S0969-8051(00)00173-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
The syntheses of four cr-aminomethyl phosphonates and their complexation studies with Tc-99m and Re-186/188 are reported. Complexation conditions were standardized to give maximum yields, which ranged from 90-97%. The yields of complexation were estimated by paper chromatography, The Tc-99m complexes were stable for more than 4 h, while the Re-186/188 complexes were stable for 3-8 days when stored at 4 degreesC. Biodistribution of these complexes in Wistar rats were carried out, and the uptake in bone and other soft tissue are detailed. Bone uptake of the Tc-99m complexes varied from 40-60% at 30 min postinjection depending on the ligands. The uptake in soft tissue was minimum with all the complexes. A comparison of the biodistribution studies of the Tc-99m complexes with that of the well-established radiopharmaceutical Tc-99m-MDP was carried out for the purpose of evaluating the efficacy of the radiopharmaceutical preparation with the complexes of these ligands. The bone uptake of the Re-186/188 complexes varied from 19-28% corresponding to 1.6-3% per g at 3 h postinjection. The residual activity in both Tc-99m and Re-186/188 complexes showed renal clearance. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:205 / 213
页数:9
相关论文
共 31 条
[1]
Arano Yasushi, 1995, Radioisotopes, V44, P514
[2]
Preparation of a cold kit of Re-186(Sn)-HEDP [J].
Bai, HS ;
Jin, XH ;
Wang, F ;
Du, J ;
Liu, YM ;
Chen, DM .
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES, 1996, 206 (01) :43-50
[3]
BEVAN JA, 1980, J NUCL MED, V21, P967
[4]
BISUNADAN MM, 1991, APPL RADIAT ISOTOPES, V42, P167
[5]
CASTRONOVO FP, 1974, J NUCL MED, V15, P127
[6]
Chilton HM, 1990, PHARM MED IMAGING, P537
[7]
COLLINS C, 1993, J NUCL MED, V34, P1839
[8]
188Re(V)-DMSA revisited:: Preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake [J].
Dadachova, E ;
Chapman, J .
NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (02) :173-181
[9]
[186/188Re] rhenium-ethylene dicysteine (Re-Ec):: Preparation and evaluation for possible use in endovascular brachytherapy [J].
Das, T ;
Banerjee, S ;
Samuel, G ;
Kothari, K ;
Unni, PR ;
Sarma, HD ;
Ramamoorthy, N ;
Pillai, MRA .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (02) :189-197
[10]
DAVIS M A, 1976, Seminars in Nuclear Medicine, V6, P19, DOI 10.1016/S0001-2998(76)80033-5